Ubie

Headquarters: Japan

Filing date: 2026-03-01

Estimated valuation: $500.0M

Executive Summary

Ubie is a top health technology company in Japan that uses computer programs to link 10 million monthly active users with more than 1,400 medical centers through a two-sided system that checks patient symptoms. The firm brings in about $60 million in yearly sales and has a total worth of $500 million, backed by big investors such as Mitsubishi UFJ Capital. While it shows a $10 million yearly loss because it is spending heavily to grow, Ubie protects its business by making its specialized software follow the specific rules of Japanese doctors and insurance plans. The company stands out because it builds its tools directly into daily hospital work and owns a massive collection of millions of medical data points. Even though it has a medium risk grade of 44 out of 100, its lead as the first big player helps fix the problem of not having enough doctors and the waste of time spent on paperwork in a country that usually avoids change. Selling its stock on the Tokyo Stock Exchange for the first time would mark a big change for software companies using artificial intelligence to help Japan's older population. This chance to buy shares represents a business that is very hard for competitors to copy as medicine moves toward being more digital and based on data.

Risk Analysis

Detailed risk factors, AI-graded risk score, financials, and analyst commentary for Ubie are available to Pro subscribers.

Unlock the full report or browse 500+ pre-IPO prospects.